The purpose of this post approval study of heart block is to gather additional information regarding how often patients develop heart block (atrioventricular block) after having standard ablation procedure using cryotherapy with the Freezor™ catheter.
Due to the lack of enrollments for the trial. The FDA and Medtronic discussed the inclusion of data found from from published literature (external studies) to corroborate study endpoint. The FDA allowed this data and the study was closed.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
105
cryoablation
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Columbia University Medical Center and the New York Presbyterian Hospital
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Device or Procedure Related AV Block Persistent Through Discharge From Hospital.
Time frame: After 250 subjects have been enrolled.
AV Block That Requires the Insertion of a Permanent Pacemaker: Defined as the Insertion of a Permanent Pacemaker, as Assessed During Defined Study Follow up.
Time frame: After 250 subjects have been enrolled.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.